ACELYRIN INC (SLRN) Forecast, Price Target & Analyst Ratings
NASDAQ:SLRN • US00445A1007
2.27 USD
+0.04 (+1.79%)
At close: May 20, 2025
2.25 USD
-0.02 (-0.88%)
After Hours: 5/20/2025, 8:00:02 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ACELYRIN INC (SLRN).
Forecast Snapshot
Consensus Price Target
$8.16
+ 259.47% Upside
Next Earnings Forecast
Release DateAug 11, 2025
PeriodQ2 / 2025
EPS Estimate-$0.51
Revenue Estimate
ChartMill Buy Consensus
85.00%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$8.16
Upside
+ 259.47%
From current price of $2.27 to mean target of $8.16, Based on 8 analyst forecasts
Low
$8.08
Median
$8.16
High
$8.40
Price Target Revisions
1 Month
0.00%
3 Months
-22.58%
Price Target Summary
8 Wall Street analysts provided a forecast for the next 12 months for SLRN. The average price target is 8.16 USD. This implies a price increase of 259.47% is expected in the next year compared to the current price of 2.27.
The average price target has been revised downward by 22.58% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
85.00%
SLRN was analyzed by 8 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about SLRN.
In the previous month the buy percentage consensus was at a similar level.
SLRN was analyzed by 8 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-01-07 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-01-07 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2024-12-11 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-12-11 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-11-14 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2024-10-16 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-08-19 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-08-15 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-08-14 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-07-08 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2024-05-22 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-09 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-04-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-21 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-03-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-12-13 | Wells Fargo | Initiate | Equal-Weight |
| 2023-12-08 | Citigroup | Initiate | Neutral |
| 2023-11-29 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-11-28 | Jefferies | Maintains | Buy -> Buy |
| 2023-11-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-13 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2023-09-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-05 | Morgan Stanley | Maintains | Overweight -> Overweight |
Next Earnings Forecast Details
Next Earnings Details
Release DateAug 11, 2025
PeriodQ2 / 2025
EPS Estimate-$0.51
Revenue Estimate
Revenue Q2QN/A
EPS Q2Q40.70%
Number of Analysts3
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
4.28%
Next Earnings Summary
SLRN is expected to report earnings on 8/11/2025. The consensus EPS estimate for the next earnings is -0.51 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A 267.11% | N/A 109.32% | N/A 49.87% | N/A 26.26% | |||||
| EBITDA YoY % growth | N/A | N/A | -421.949M | -290.141M 31.24% | N/A 34.18% | N/A -3.42% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -41.794M | -69.179M -65.52% | -422.064M -510.10% | -290.564M 31.16% | N/A 21.81% | N/A 3.08% | N/A -5.85% | N/A 0.44% | N/A 78.24% | N/A 441.41% | N/A 112.72% | N/A 41.17% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | -4.35 | -2.80 35.63% | N/A 26.89% | N/A 8.49% | N/A -7.80% | N/A 41.92% | N/A 61.74% | N/A 95.45% | N/A 2,950.00% | N/A 49.12% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.51 40.70% | -0.61 23.35% | -0.77 3.16% | -0.62 -13.13% | -0.60 -18.00% | -0.62 -2.75% | -1.38 -80.00% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | |||
| EBITDA Q2Q % growth | -58.699M 25.28% | -59.144M -35.46% | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -58.14M 26.15% | -59.874M -36.27% | -64.08M 24.72% | -63.661M -6.36% | -62.362M -7.26% | -64.85M -8.31% | -67.457M -5.27% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
8.54%
EPS Next 5 Year
12.97%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
ACELYRIN INC / SLRN Forecast FAQ
What is the average price target for ACELYRIN INC (SLRN) stock?
8 analysts have analysed SLRN and the average price target is 8.16 USD. This implies a price increase of 259.47% is expected in the next year compared to the current price of 2.27.
What is the next earnings date for SLRN stock?
ACELYRIN INC (SLRN) will report earnings on 2025-08-11.
What are the consensus estimates for SLRN stock next earnings?
The consensus EPS estimate for the next earnings of ACELYRIN INC (SLRN) is -0.51 USD and the consensus revenue estimate is 0 USD.
Can you provide the consensus rating for ACELYRIN INC stock?
The consensus rating for ACELYRIN INC (SLRN) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.